why choose us

First received: September 11, 2023

Clinical Trial: Effect of Acetylcholinesterase Inhibitors on Bone Metabolism

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Osteoporosis

Study Type: INTERVENTIONAL


Official Title: Effect of Acetylcholinesterase Inhibitors on Bone Metabolism and Fracture Risk Factors Among Older Adults With Mild to Moderate Alzheimer's Disease

Brief Summary: People with Alzheimer's disease are at an increased risk of bone fracture.Some studies have shown that those taking donepezil have a lower rate of bone fractures, but the reasons for this are unknown.The purpose of this study is to measure the effect of donepezil treatment on bone metabolism factors including bone mineral density, bone turnover markers, and bone quality.Participants in this study will have a bone density test and have blood samples collected at the baseline study visit.Participants will then…

Read more